Western blots further confirmed that the higher levels of tau hyperphosphorylation (47.2% and 51.4% increase of p-tau 231 and p-tau 396, both P <0.01) in AD control mice than those of WT control mice in the cortex (Fig. 4B, 4D). This evidence concerns the gene MAPT and Alzheimer disease.